Key result
Sacubitril/valsartan shows safe and rapid LVEF improvement in a heart failure patient with hairy cell leukemia.
Why the study?
Experience with angiotensin-receptor neprilysin inhibitors in oncologic patients with heart failure is limited.
Does sacubitril/valsartan improve symptoms and cardiac function in a patient with relapsing hairy cell leukaemia and heart failure with reduced LVEF?
Case Report (n=1)
Does sacubitril/valsartan improve symptoms and cardiac function in a patient with relapsing hairy cell leukaemia and heart failure with reduced LVEF?
Answers are grounded in this paper and cite their sources.
Sacubitril/valsartan was safe and effective in improving heart failure in a patient with relapsing hairy cell leukaemia, enabling the initiation of necessary antineoplastic therapy.
Experience with angiotensin-receptor neprilysin inhibitors (ARNI) in oncologic patients with heart failure (HF) is limited. We report a case of ARNI started as first-choice therapy in a patient with relapsing hairy cell leukaemia (HCL) and HF with depressed left ventricular ejection fraction (LVEF). A middle-aged male, previously treated with rituximab for HCL, was scheduled for cardiologic screening before starting a new antineoplastic therapy for cancer relapse. The patient had symptomatic HF with reduced LVEF and high NT-proBNP levels. In this patient, early ARNI treatment was well tolerated and produced a rapid and durable improvement of symptoms, LVEF and NT-proBNP levels. Consequently, the oncologic team could start an experimental treatment with obinutuzumab, with complete HCL remission. In conclusion, in this patient with HCL and HF, ARNI therapy was safe and effective, contributing to undelayed cancer treatment.
No takes yet. Share an insight, caveat, or question.
Lupi et al. (2021) conducted a case report in Heart failure and relapsing hairy cell leukaemia (n=1). Sacubitril/Valsartan (ARNI) was evaluated on Symptoms, LVEF and NT-proBNP levels. Sacubitril/Valsartan therapy was safe and effective in a patient with relapsing hairy cell leukaemia and heart failure, producing rapid improvement in symptoms, LVEF, and NT-proBNP levels.
Synapse has enriched 10 related papers. Consider them for comparative context: